Skip to main content
Premium Trial:

Request an Annual Quote

You Can't Get Those Guys to Do Anything Together

It's been four years and the California Institute of Regenerative Medicine is barely off the ground. In June, its newest director, Alan Trounson, allotted $23 million in funding for research on human embryonic stem cells as well as iPS adult stem cell lines, according to the Wall Street Journal. Next, Trounson will fund teams to focus on specific diseases and he hopes to take those therapies to clinical trials within five years. The biggest challenge, however, might be getting academic researchers, state legislatures, and pharmaceutical companies to work together to make that goal a reality.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.